Почетна › Рак на бели дробови со не-мали клетки › Флорида › Orlando
Клинички испитувања за Рак на бели дробови со не-мали клетки во Orlando, FL
44 студии за Рак на бели дробови со не-мали клетки бараат учесници на локации во и околу Orlando (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Се регрутираФаза 1/2
- Orlando Health Cancer Institute (Melanoma/NSCLC), Orlando
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Се регрутираФаза 1/2
- Advent Health, Orlando
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Се регрутираФаза 1
- Exelixis Clinical Site #48, Celebration · на 17 милји
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Се регрутираФаза 2
- AdventHealth Medical Group Oncology Research at Celebration, Kissimmee · на 16 милји
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Се регрутираФаза 3
- Clermont Oncology Center, Clermont · на 24 милји
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Се регрутираФаза 3
- AdventHealth Cancer Institute, Orlando
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Се регрутираФаза 2
- AdventHealth, Orlando
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Се регрутираФаза 3
- Florida Cancer Specialists, Orlando
- Orlando Health Ambulatory Care Center, Orlando
- Orlando Health Cancer Institute, Orlando
- и уште 4
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Се регрутираФаза 2
- Orlando Health Cancer Institute, Orlando
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Се регрутираФаза 2
- AdventHealth Orlando, Orlando
- Orlando Health Cancer Institute, Orlando
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Се регрутираФаза 1/2
- Orlando Health Ambulatory Care Center, Orlando
- Orlando Health Cancer Institute, Orlando
- Orlando Health Orlando Regional Medical Center, Orlando
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Се регрутираФаза 3
- Research Site, Orlando
- Research Site, Clermont · на 24 милји
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Се регрутираФаза 2/3
- Clermont Oncology Center, Clermont · на 24 милји
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Се регрутираФаза 1
- Sara Cannon Research Institute Lake Nona, Orlando
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
Се регрутираФаза 1
- AdventHealth, Orlando
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Се регрутираФаза 3
- Clinical Study Site, Orlando
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Се регрутираФаза 1
- Advent Health Medical Group Radiation Oncology at Central Florida, Orlando
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Се регрутираФаза 2/3
- AdventHealth Orlando, Orlando
- Local Institution - 007-896-A, Celebration · на 17 милји
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
Се регрутираФаза 1/2
- Sarah Cannon Research Institute at Florida Cancer Specialists- Lake Nona, Orlando
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Се регрутираФаза 3
- Orlando Health Cancer Institute, Orlando
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Се регрутираФаза 1
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Се регрутираФаза 1
- Sarah Cannon Research Institute - Florida Cancer Specialists, Orlando
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Се регрутираФаза 1
- Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute, Orlando
SMP-3124LP in Adults With Advanced Solid Tumors
Се регрутираФаза 1/2
- Advent Health, Celebration · на 17 милји
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Се регрутираФаза 1/2
- AdventHealth Celebration, Celebration · на 17 милји
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Се регрутираФаза 1/2
- Sarah Cancer Research Institution - Florida Cancer Specialist, Orlando
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Се регрутираФаза 1/2
- Clermont Oncology Center, Clermont · на 24 милји
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Се регрутираФаза 1
- Florida Cancer Specialists - Lake Nona, Orlando
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Се регрутираФаза 1
- Florida Cancer Specialists, Orlando
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Се регрутираФаза 1
- Florida Cancer Specialists, Orlando
A Study of LY4175408 in Participants With Advanced Cancer
Се регрутираФаза 1
- Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute, Orlando
Study of XB010 in Subjects With Solid Tumors
Се регрутираФаза 1
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Се регрутираФаза 1/2
- Orlando Health Cancer Institute, Orlando
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Се регрутираФаза 1
- Research Site, Orlando
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Се регрутираФаза 1
- AdventHealth Celebration, Celebration · на 17 милји
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Се регрутираФаза 2
- Clermont Oncology Center, Clermont · на 24 милји
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
Се регрутираФаза 3
- Advent Health, Orlando
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Се регрутираФаза 1/2
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Се регрутираФаза 1
- AdventHealth Cancer Institute, Celebration · на 17 милји
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Се регрутираФаза 1/2
- Florida Cancer Specialists-Lake Nona, Orlando
GEMINI-NSCLC: NSCLC Biomarker Study
Се регрутираНабљудувачка студија
- Clermont Oncology Center, Clermont · на 24 милји
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
Се регрутираФаза 1
- Florida Cancer Specialists & Research Institute, Orlando
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Се регрутираФаза 1
- Dren Investigational Site, Orlando
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Се регрутираФаза 1/2
- Research Site 137, Orlando
- Research Site 118, Celebration · на 17 милји
Испитувања за Рак на бели дробови со не-мали клетки во други градови
- Houston, TX145 студии
- New York City, NY121 студија
- Arlington, VA104 студии
- Nashville, TN97 студии
- Boston, MA90 студии
- Los Angeles, CA87 студии
- St. Louis, MO73 студии
- Chicago, IL61 студија
- Baltimore, MD60 студии
- San Antonio, TX59 студии
- Columbus, OH57 студии
- Washington, DC55 студии
Други студии во Orlando
- Дебелина32 студии
- Метастатски карцином29 студии
- Прекумерна телесна тежина27 студии
- Алцхајмерова болест25 студии
- Дијабетес тип 225 студии
- Рак (сите типови)24 студии
- Рак на дојка23 студии
- Карцином на јајниците22 студии
- Улцерозен колитис22 студии
- Рак на бели дробови21 студија
- Колоректален карцином19 студии
- Голема депресивна нарушување19 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.